Viral Vector Manufacturing: Production Capacity & Pricing Report

Viral Vector Manufacturing: Production Capacity & Pricing Analysis

Table of Contents

Chapter 1. Viral Vector Manufacturing Analysis Overview
                   1.1. Funding and Investment Scenario
                   1.2. Regulatory Landscape
                   1.3. Technology Landscape
Chapter 2. Viral Vector Manufacturing Pricing Analysis Overview
                   2.1. Viral Vector Pricing Analysis Snapshot, 2023:
                       2.1.1. Parameters affecting price
                       2.1.2. AAV: pricing analysis
                       2.1.3. Lentivirus: pricing analysis
                       2.1.4. Adenovirus: pricing analysis
                       2.1.5. Retrovirus: pricing analysis
                       2.1.6. Gene synthesis cost
                       2.1.7. Genes/ gene fragment cost analysis
Chapter 3. Viral Vector Product Capacity Analysis Overview
                   3.1. Viral Vector Product Capacity Analysis Snapshot, 2023:
                   3.2. Manufacturing & Production Capacity Analysis, by Region
                       3.2.1. North America
                       3.2.2. Europe
                       3.2.3. Asia Pacific
Chapter 4. Competitive Landscape
                   4.1. Overview of Key Players
                       4.1.1. Merck KGaA
                           4.1.1.1. Financial Performance
                           4.1.1.2. Strategic Initiatives
                       4.1.2. Lonza
                       4.1.3. FUJIFILM Holdings Corporation
                       4.1.4. Thermo Fisher Scientific, Inc.
                       4.1.5. Charles River Laboratories (Cobra Biologics)
                       4.1.6. Catalent Inc.
                       4.1.7. Wuxi Biologics
                       4.1.8. Takara Bio Inc.
                       4.1.9. Genezen
                       4.1.10. Batavia Biosciences
                       4.1.11. Miltenyi Biotec
                       4.1.12. Revvity Inc. (SIRION Biotech)
                       4.1.13. Virovek Incorporation
                       4.1.14. BioNTech IMFS
                       4.1.15. Audentes Therapeutics
                       4.1.16. BioMarin
                       4.1.17. RegenxBio, Inc.
                       4.1.18. Waisman Biomanufacturing
                   4.2. List of Emerging Players



What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo